Basic info
Industry
biotechnology research
Sectors
cell dormancy
precision oncology
Biotechnology
Targeted therapy
TET2
Spin-off
biopharmaceutical
first-in-class
Therapeutics
cancer
Biopharma
cancer persistence
Date founded
2021
Funding rounds raised
Total raised
$1.4M
from 1 investors over 1 rounds
O
Oniria Therapeutics raised $1.4M on May 11, 2023
Investors: Fundación Botín